T. Otz, L. Grosse-hovest, M. Hofmann, H. Rammensee, and G. Jung, A bispecific single-chain antibody that mediates target cell-restricted, supra-agonistic CD28 stimulation and killing of lymphoma cells, Leukemia, vol.27, issue.1, pp.71-78, 2009.
DOI : 10.1038/leu.2008.271

L. Grosse-hovest, W. Wick, R. Minoia, M. Weller, H. Rammensee et al., Supraagonistic, bispecific single-chain antibody purified from the serum of cloned, transgenic cows induces T-cell-mediated killing of glioblastoma cellsin vitro andin vivo, International Journal of Cancer, vol.170, issue.6, pp.1060-1064, 2005.
DOI : 10.1002/ijc.21294

M. Mack, G. Riethmuller, and P. Kufer, A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity., Proceedings of the National Academy of Sciences, vol.92, issue.15, pp.7021-7026, 1995.
DOI : 10.1073/pnas.92.15.7021

A. Loffler, P. Kufer, R. Lutterbuse, F. Zettl, P. Daniel et al., A recombinant bispecific single-chain antibody, CD19 CD3, induces rapid and high × lymphoma-directed cytotoxicity by unstimulated T lymphocytes, Blood, vol.95, pp.2098-103, 2000.

P. Baeuerle and C. Reinhardt, Bispecific T-Cell Engaging Antibodies for Cancer Therapy, Cancer Research, vol.69, issue.12, 2009.
DOI : 10.1158/0008-5472.CAN-09-0547

E. Wolf, R. Hofmeister, P. Kufer, B. Schlereth, and P. Baeuerle, BiTEs: bispecific antibody constructs with unique anti-tumor activity, Drug Discovery Today, vol.10, issue.18, pp.1237-1281, 2005.
DOI : 10.1016/S1359-6446(05)03554-3

K. Brischwein, L. Parr, S. Pflanz, J. Volkland, J. Lumsden et al., 200 POSTER Strictly target cell-dependent activation of T cells by bispecific single-chain antibody constructs of the BITE class, European Journal of Cancer Supplements, vol.4, issue.12, pp.798-807, 2007.
DOI : 10.1016/S1359-6349(06)70205-1

S. Offner, R. Hofmeister, A. Romaniuk, P. Kufer, and P. Baeuerle, Induction of regular cytolytic T cell synapses by bispecific single-chain antibody constructs on MHC class I-negative tumor cells, Molecular Immunology, vol.43, issue.6, pp.763-71, 2006.
DOI : 10.1016/j.molimm.2005.03.007

R. Kirschel, S. Hausman, M. Klinger, P. Baeuerle, and P. Kufer, Effector memory T cells make a major contribution to redirected target cell lysis by T cell-engaging BiTE antibody MT110, Annual Meeting of AACR, issue.3252, 2009.

A. Boesteanu and P. Katsikis, Memory T cells need CD28 costimulation to remember, Seminars in Immunology, vol.21, issue.2, pp.69-77, 2009.
DOI : 10.1016/j.smim.2009.02.005

T. Dreier, P. Baeuerle, I. Fichtner, M. Grun, B. Schlereth et al., T Cell Costimulus-Independent and Very Efficacious Inhibition of Tumor Growth in Mice Bearing Subcutaneous or Leukemic Human B Cell Lymphoma Xenografts by a CD19-/CD3- Bispecific Single-Chain Antibody Construct, The Journal of Immunology, vol.170, issue.8, pp.4397-402, 2003.
DOI : 10.4049/jimmunol.170.8.4397

B. Schlereth, C. Quadt, T. Dreier, P. Kufer, G. Lorenczewski et al., T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct, Cancer Immunology, Immunotherapy, vol.135, issue.Suppl2, pp.503-517, 2006.
DOI : 10.1007/s00262-005-0001-1

R. Bargou, E. Leo, G. Zugmaier, M. Klinger, M. Goebeler et al., Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody, Science, vol.321, issue.5891, pp.974-981, 2008.
DOI : 10.1126/science.1158545

K. Brischwein, B. Schlereth, B. Guller, C. Steiger, A. Wolf et al., MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors, Molecular Immunology, vol.43, issue.8, pp.1129-1172, 2006.
DOI : 10.1016/j.molimm.2005.07.034

B. Schlereth, I. Fichtner, G. Lorenczewski, P. Kleindienst, K. Brischwein et al., Eradication of Tumors from a Human Colon Cancer Cell Line and from Ovarian Cancer Metastases in Immunodeficient Mice by a Single-Chain Ep-CAM-/CD3-Bispecific Antibody Construct, Cancer Research, vol.65, issue.7, pp.2882-2891, 2005.
DOI : 10.1158/0008-5472.CAN-04-2637

M. Amann, K. Brischwein, P. Lutterbuese, L. Parr, L. Petersen et al., Therapeutic Window of MuS110, a Single-Chain Antibody Construct Bispecific for Murine EpCAM and Murine CD3, Cancer Research, vol.68, issue.1, pp.143-51, 2008.
DOI : 10.1158/0008-5472.CAN-07-2182

D. Sanders, A. Evans, C. Allen, F. Bryant, G. Johnson et al., Classification of CEA-related positivity in primary and metastatic malignant melanoma, The Journal of Pathology, vol.173, issue.4, pp.343-351, 1994.
DOI : 10.1002/path.1711720409

R. Lutterbuese, T. Raum, R. Kischel, P. Lutterbuese, B. Schlereth et al., Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA, Journal of Immunotherapy, vol.32, issue.4, 2009.
DOI : 10.1097/CJI.0b013e31819b7c70